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Cartilage volumetryAbstract Background: The metabolic imbalance in the articular cartilage following meniscectomy
includes an increase in cartilage degradation with an insufﬁcient reparative or anabolic response
resulting in structural, biochemical and mechanical changes that can progress from pre-clinical,
to pre-radiographic, to radiographic damage of the joint.
Purpose: To evaluate combinations of imaging and biochemical biomarkers for cartilage
breakdown, synthesis and quantity in the early period of post-arthroscopic meniscectomy.
Subjects and methods: Twenty young adults (three of them were females) who underwent unilateral
arthroscopic partial meniscectomy were evaluated. The patients had a mean age of 32.5 years
(range, 24–39), mean BMI of 28.5 kg/m2 (range, 24–34). Preoperative and six months postoperative
US and MRI-based markers (cartilage thickness and volume, respectively) were quantiﬁed for med-
ial and lateral tibio-femoral compartments for both knees. Preoperative, three and six months post-
operative biochemical markers serum assays were measured; COMP and Col II (cartilage matrix
breakdown) and PIICP (cartilage synthesis). These three markers were measured in an age, sex
and BMI matched twenty healthy subjects for comparison.en type
ollagen
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192 H.K. Koryem et al.Results: The meniscectomized knees had signiﬁcantly lower total knee cartilage volume, P< 0.05
but non-signiﬁcant mean thickness than the intact contralateral knees. Among the individual bio-
chemical markers, PIICP had the highest signiﬁcant diagnostic accuracy quantiﬁed as the area
under the receiver-operator characteristics curve (AUC) of 0.75 (95% conﬁdence interval: 0.509–
0.912) higher than all others, P< 0.05 to distinguish subjects with progressive cartilage loss from
non-progressors. Diagnostically, ratio of COMP and Col II to PIICP scored AUC of 0.90 (0.69–
0.98, higher than PIICP: P= 0.0001). For prediction of cartilage loss, none of the individual mark-
ers could be used.
Conclusion: Cartilage volume loss by MRI combined with changes in cartilage matrix turnover
detected by molecular biomarkers may reﬂect the initial changes associated with cartilage degener-
ation that account for early OA.
ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Knee trauma, such as cruciate ligament or meniscus injury, is a
strong predictor of subsequent knee osteoarthritis (OA). Con-
sidering the young age at which many of these injuries occur,
knee joint replacement at a relatively young age is a distinct
possibility.1 So, secondary prevention of OA is important.
The hallmark of OA is loss of articular cartilage which is char-
acterized by high wear resistance, and poor regenerative qual-
ities.2 Osteoarthritis is a disease with a long silent period. Early
identiﬁcation of OA is crucial to improve clinical decision
making and advancing treatment options. Thus preventing
further cartilage destruction and joint failure, especially in ath-
letes, in whom unnecessary treatment or intervention may be
detrimental to a competitive future. Hence, diagnostic tests
that can detect and monitor molecular events early in the path-
ogenesis of OA would be potentially very useful.3
A variety of risk factors work together to incite a cascade of
pathophysiologic events within joint tissues leading to OA
including advancing age, gender, genetics, obesity and trauma.
The repetitive nature of stress on a previously healthy, yet
traumatized, articular surface, has also been related with early
cartilage changes and degeneration that may stay invisible for
a long period of time before evolving into irreversible cartilage
lesion.4
The menisci are two semilunar-shaped ﬁbrocartilaginous
structures, containing water, collagen (mainly type I), and
proteoglycans. Their unique anatomy is comprised of circum-
ferentially oriented collagen ﬁbers which provide resistance
to hoop stresses and radially oriented ﬁbers which resist
shear forces.5 Long-term follow-up studies showed that virtu-
ally all meniscectomized knees develop arthritic changes with
time.1 The severity of these changes seems to be proportional
to the amount of meniscus removed.6 The frequent bone and
cartilage changes found after partial meniscectomy are
thought to be due to the decrease in contact area up to
50–70% with a resulting increase in contact stresses,6 and
loss of the load distributing function which prevents the
menisci from extruding out the joint during axial loading
and decreased stability of the knee.7 Moreover, as 74% of
the total weight of the meniscus is water which could be
squeezed out into the joint space during compression forces
adding to the joint lubrication, thus increased coefﬁcient of
friction between the gliding joint surfaces is one of the con-
sequences of meniscectomy.7The increased intra-articular contact stresses within the
knee are thought to ‘overload’ the articular cartilage, with
associated structural, biochemical and mechanical changes.
The macroscopic and microscopic signs of failure of articular
cartilage after meniscectomy have also been demonstrated by
animal models, ranging from ﬁbrillation of the surface to
necrosis and loss of the cartilage layer.8
Cartilage is a connective tissue made of cells (chondro-
blasts/chondrocytes) that produce an extracellular matrix of
proteoglycans and collagen ﬁbers with high water content.
The tensile strength of cartilage is due to the collagen compo-
nent. Its resistance to compression is due to the ability of pro-
teoglycan to attract and hold water.9
Biomarker is a detectable biologic parameter, whether bio-
chemical, genetic, histologic, anatomic, physical, functional, or
metabolic.10 Biomarkers are used in diagnosis of disease, in
addition they allow classiﬁcation of disease severity, risk of
onset and progression, as well as assessment of the efﬁcacy
of a treatment.10
Cartilage imaging biomarkers have gained a signiﬁcant role
in various aspects of OA. Magnetic resonance imaging (MRI)
is the most promising imaging modality to detect structural
changes in cartilage tissue, as it is direct and noninvasive.11
MR-based morphological cartilage biomarkers are superior
to radiographs in characterizing disease burden. Their role in
characterizing prognosis and risk of OA is showing great
promise. Many techniques enable imaging of ﬁssuring and
focal or diffuse cartilage loss. The 3D-spoiled gradient recalled
echo imaging with fat suppression either using selective fat
suppression or selective water excitation provide higher spatial
and contrast resolution, and are the current standard for mor-
phological imaging of cartilage.12 The articular cartilage has a
very high signal intensity, joint ﬂuid has an intermediate to low
signal intensity, and subchondral bone and bone marrow are
dark. Reported sensitivity and speciﬁcity for directly assessing
knee structural alterations, such as cartilage volume, cartilage
defects, subchondral bone changes and meniscal lesions are
75–85% and 95–97%, respectively, which has increased our
understanding of early joint changes.13
Morphologic changes in the cartilage matrix and chondro-
cytes could be detected on the molecular level. The molecules
released could be measured by biochemical markers. Measure-
ment of biochemical markers in blood, urine or synovial ﬂuid
samples could reﬂect dynamic and quantitative changes in
joint remodeling and therefore disease progression. Because
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matrix, the assessment of its synthesis and degradation is an
attractive approach for the investigation of OA and can be
assessed by several markers.14
The procollagen molecule of type II collagen has large
amino and carboxyl-terminal regions (N-propeptides and
C-propeptides, respectively) at each end. During synthesis,
these propeptides are removed by speciﬁc proteases before
the mature molecules are incorporated into ﬁbrils. The
C-propeptide can be detected by a PIICP assay. Two assays
that recognize N-propeptides; the N-propeptide of type IIA
procollagen (PIIANP) and the total PIINP have been devel-
oped. The serum levels of these propeptides are thus believed
to represent an adequate index of the rate of type II collagen
synthesis.15
Other biomarkers are related to cartilage matrix turnover
and degradation including collagenous (e.g. C-terminal telo-
peptide of collagen type II, human collagen type II-speciﬁc
neoepitope (C2M) and cartilage cleavage products) and non-
collagenous proteins (e.g. cartilage oligomeric matrix protein,
COMP). Serum levels of COMP, a member of the thrombo-
spondin family of glycoproteins, have been shown to be
increased in individuals with knee OA and synovitis, compared
to those without synovitis.16
So, there are a number of promising imaging and biochem-
ical cartilage biomarkers although none is sufﬁciently discrim-
inating to differentiate between individual patients and
controls (diagnostic) or between patients with different disease
severities (burden of disease), predict prognosis in individuals
with or without osteoarthritis (prognostic) or perform so con-
sistently that it could function as a surrogate outcome in clin-
ical trials (efﬁcacy of intervention). Combining imaging and
biochemical biomarkers is likely to increase the predictive
power of future ‘combination biomarkers’.17
The aim of this study was to evaluate combinations of
imaging and biochemical biomarkers for articular cartilage
breakdown, synthesis and quantity in the early period post-
arthroscopic meniscectomy among Egyptians performing par-
tial meniscectomy.
2. Subjects
Twenty young adults who underwent arthroscopic partial
meniscectomy were evaluated. The patients with a mean age
of 32.5 years (range, 24–39) and mean body mass index of
28.5 kg/m2 (range, 24–34) comprised 17 men and three
women. All patients were given a preoperative diagnosis of
torn medial meniscus by history, physical examination, and
conﬁrmatory MRI.
General criteria for exclusion from the study were as
follows:
- Age older than 50 years at the time of evaluation (to exclude
idiopathic osteoarthritis according to the ACR criteria18).
- The presence of inﬂammatory arthritides.
- Surgery at any joint before.
- Diabetes mellitus, neurological or muscular disease
(because these comorbid conditions will affect the patient
relevant outcome).
- Varicose veins of the lower limbs.
- Any contraindication to MRI examination.Knee-speciﬁc criteria for exclusion (either knee) were:
- Previous knee surgery (other than meniscus surgery).
- Osteochondritis dissecans.
- Osteochondromatosis.
- Fracture in or adjacent to the knee.
- Septic arthritis.
- Osteonecrosis.
- Chondromalacia patellae.
- Patellar subluxation.
- Radiographic changes indicating knee OA at the time of
index surgery.
In summary, these were otherwise healthy patients with
previously healthy knees who experienced relatively recent
onset of knee symptoms caused by meniscal pathology.
Controls for imaging modalities were the ‘‘non-operated’’
knees of the same patients. The control group for the clinical
and biochemical markers evaluation was twenty healthy indi-
viduals of matched age and gender to the patients.
A full informed consent was signed from all participants and
this studywas formally approved by theEthicsCommittee of the
Faculty of Medicine, Alexandria University with the following
ID:[IRB No. 00007555-FWA No. 00015712,November 2011.
2.1. Methods
All patients were subjected to: (1) thorough general and men-
iscectomy related history taking focusing on articular cartilage
status, amount of resection and the knee injury and osteoar-
thritis outcome score (KOOS) questionnaire, Swedish version
LK 1.0,19 which was used to quantify knee-related symptoms.
The KOOS was developed for short and long-term follow up
studies of knee injury and knee OA. KOOS comprises ﬁve sub-
scales: pain, symptoms, activities of daily living, sports and
recreation function, and knee-related quality of life. A score
from 0 to 100 is calculated for each subscale, with 100 repre-
senting the best result. Patients were instructed to complete
the KOOS form by considering their operated knee. Control
subjects were asked to consider their knees in general. (2) Gen-
eral and local knee joint examination.
(3) MR images10 were acquired with a 1.5-T superconduc-
ting MRI-system (Gyroscan Intera, Philips Medical Systems)
using a dedicated phased-array knee coil. A positioning device
was used to ensure uniformity of positioning among patients.
The subjects were scanned in a supine position with no load-
bearing during or prior to scanning. Sagittal and coronal,
three-dimensional (3D), water selective (WatS), balanced
steady-state free precession (3D-WS-bSSFP) sequence; Fast
Field Echo (FFE) technique was done, (TR 20 ms [shortest];
TE 8 ms [shortest]; 2.0-mm slice thickness; slice overlap 1 mm;
75 slices; 130 mm FOV; 256 · 256 acquisition matrix; voxel size
0.51 · 0.51 · 2.00 mm; ﬂip angle: 25; Number of Signals Aver-
aged (NSA) 2; automatic shim; 1:1 water excitation [Proset: a
frequency selective and spatially selective binomial shaped
water excitation pulse with a pulse duration of 3.41 ms]; band-
width/pixel: 98.6; acquisition time ﬁveminutes). Cartilage is vis-
ible as a light gray or white band between the dark1
subchondral endplate and the gray joint ﬂuid (Fig. 1a).
The sagittal and coronal WS-bSSFP sequence images were
analyzed quantitatively. Cartilage volumes for the medial and
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posterior cartilage plates, and on the medial and lateral plates
of the tibia. This was performed twice; preoperative and six
months postoperative for the operated knees and once for
the normal knees at the postoperative scan time. All cartilage
contours were drawn manually (Fig. 1b). 3D geometric models
of cartilage plates of the knee joints were constructed using
these contours (Fig. 1c). Morphometric data were acquired
from computer-assisted segmentation of MR images.
(3) High resolution ultrasonography (US),20 using Siemens
Prima apparatus, utilizing high resolution multi-frequency
probe (3.5–7 MHz) was used to assess knee joint for cartilage
thickness, irregularities and effusion using transverse suprapa-
tellar scans tangential to the upper patellar pole at 90 knee
ﬂexion. The cartilage thickness was measured within the
weight-bearing area from four anatomical locations; namely,
the medial femoral condyle (MFC), the lateral femoral condyle
(LFC), the medial tibial condyle (MTC), and the lateral tibial
condyle (LTC). The femoral cartilage typically appears as a
clear-cut, wavy hypo-anechoic layer, with upper concavity.
Measurements were done two times preoperative and six
months postoperative for the operated knees and once for
the normal knees at the postoperative scan time.
(4) Biochemical markers assay: serum samples were
obtained thrice preoperatively, three and six months postoper-
atively for the patients and once for the controls. The serum
was thawed and aliquoted to 0.5-ml volumes, and then stored
at 80 C until analyzed. From the available markers, a com-
bination of human cartilage oligomeric matrix protein (COMP)
and collagen type II-speciﬁc neoepitope (Col II); (for cartilage
matrix breakdown) and procollagen molecule of type II
collagen C-propeptides (PIICP); (for cartilage synthesis) were
assayed. The three markers were measured with a commercial
sandwich enzyme-linked immunosorbent assay (ELISA)
(Cusabio Biotech Co, Hubei Province, China). For all ELISA
determinations, samples, standards, and controls were assayed
according to the manufacturer’s instructions.21 The samples were
assayed in a blinded manner, independent of group assignment.
The mean intra-assay precision was <8% coefﬁcient of variation
(CV) and inter-assay CV <10% for all assays.
Data were analyzed using the Statistical Package for Social
Sciences (SPSS ver. 17, Chicago, IL, USA). The data were
reported as mean and standard deviation. T-tests and chi-
square tests were used to compare differences in means and
proportions where appropriate. The data were compared
between the operated and contralateral control knees using
paired t-test. Morphometric cartilage change was reported as
mean change. The percentage change in pre- and post-opera-Figure 1 Cartilage volume quantiﬁcation framework. (a) sagittal W
light gray or white band between the dark subchondral endplate and t
3D geometric model of the medial tibial cartilage plate.tive scans in cartilage volume and thickness was compared
with biochemical marker assay change using independent
two-sample t-test. Statistical signiﬁcance level was set at 0.05.3. Results
There was no signiﬁcant difference between patients and con-
trols regarding age (32.5 ± 4.7 vs. 30.8 ± 3.5; n.s.), sex
(v= 0.305; n.s.), or BMI (28.5 ± 3.2 vs. 26.7 ± 4; n.s.). The
mean time from injury was 6.4 ± 2.6 months. The mechanism
of injury was signiﬁcant trauma in 50% of patients. The
amount of meniscus removed was >60% of the medial menis-
cus in 88% of patients. Articular chondral lesions were deﬁned
arthroscopically in two patients (10%). There was a signiﬁcant
improvement in the KOOS scores 3 and 6 months post-opera-
tively compared to pre-operatively (81 ± 7 and 86 ± 5.4 vs.
64 ± 10; P< 0.05).
3.1. Imaging biomarkers
The meniscectomized knees demonstrated a statistically signif-
icant decrease in total ‘medial’ tibiofemoral cartilage volume
compared with the control side post-operatively (5.04 ±
1.19 cm3 vs. 6.15 ± 0.92 cm3; P= 0.001) but no signiﬁcant dif-
ference was found between both pre-operatively 6.05± 0.9 cm3 vs.
6.15 ± 0.92 cm3; n.s.). Additionally, there was a signiﬁcant
reduction in total ‘lateral’ tibiofemoral cartilage volume com-
pared with the control side post-operatively (6.1 ± 0.5 cm3
vs. 6.9 ± 0.9 cm3; P= 0.0020) but no signiﬁcant difference
was found between both pre-operatively (7 ± 0.1 cm3s. vs.
6.9 ± 0.9 cm3; n.s.). The percentage of decrease in the total
knee cartilage volume post-operatively from pre-operatively
was >10% in 13 patients (65%), this indicates progressors
of cartilage loss based on MRI measurements of cartilage
volume as a biomarker.
Compared with the control side, the meniscectomized side
demonstrated no statistically signiﬁcant difference in total
knee cartilage thickness measured by US in this cohort
(2.0 ± 0.2 mm vs. 1.9 ± 0.3 mm, n.s.). In addition, no signiﬁ-
cant difference was observed for the cartilage thickness in each
part of the cartilage.
3.2. Biochemical markers
A signiﬁcant difference was found between the patients at the
preoperative markers assay and controls in both the COMP
(588.8 ± 566.7 vs. 133.8 ± 65 ng/ml; P< 0.05) and PIICPS-bSSFP sequence with optimal contrast. Cartilage is visible as a
he gray joint ﬂuid. (b) The outlines of the knee cartilage plates. (c)
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II (29.8 ± 28.7 vs. 45.1 ± 31.3 ng/ml; P< 0.05).
There was an increase in the COMP and Col II assays
between 3 and 6 months postoperatively, however, this was not
signiﬁcant. A signiﬁcant decrease in PIICP was found between
3 and 6 months post-operatively in all patients (Table 1).
Diagnostically, with the exception of PIICP, none of the
individual biochemical biomarkers was a statistically signiﬁ-
cant indicator of cartilage volume loss by MRI. PIICP had
the highest diagnostic accuracy quantiﬁed as the area under
the receiver-operator characteristics curve (AUC) of 0.75
(95% CI: 0.509–0.912) higher than all others, P< 0.05, to dis-
tinguish subjects with progressive cartilage loss from non-pro-
gressors. However on combinations, the ratio of COMP and
Col II to PIICP scored AUC of 0.906 (0.69–0.98, was higher
than PIICP.
The prognostic performance was deﬁned as the ability of the
percentage of change in the three measured biochemical markers
from pre-operative to 3 months and from 3 to 6 months post-
operative values to separate non-progressors (no or <10%
change in the cartilage volume pre- and post-operatively) from
early progressors (>10% change), and was evaluated by the P
value from multivariate analysis of variation (based on Hotell-
ing’s T2 test, none of the markers nor their change could predict
progression of volume loss byMRI.Multivariable logistic regres-
sion revealed signiﬁcant associations of increased COMP and
Col II (95% CI= 0.85–7.82) and decreased PIICP (95%
CI= 1.2–9.3) with the presence of cartilage volume loss
>10%, independent of age and duration after injury. The com-
bined impact of increased COMP and Col II and decreased
PIICP was 20.9 (95%CI= 1.97–235.3), far exceeding the impact
of each independent biomarker.4. Discussion
In this study serum levels of COMP, Col II and PIICP are
modestly associated with cartilage volume loss by MRI, but
not with its progression, in a group of twenty young Egyptian
adults who underwent unilateral arthroscopic partial
meniscectomy.
Knee cartilage is an important structure in the human body
and plays a pivotal role in knee joint activity. It is known that
cartilage morphology is inﬂuenced by many factors, such as
age, gender, genetics, BMI, level of physical activity, osteoar-
thritis, pain and ACL or meniscal injuries.22 Among these fac-
tors, meniscal damage appears to be an important factor to
induce cartilage morphological changes. Meniscal damage orTable 1 Change in biochemical markers assays at 3 and 6 months
Biochemical marker Mean St
COMP change at 3 m 119.9885 23
COMP change at 6 m 166.0748 30
Coll change at 3 m 28.5714 5
Coll change at 6 m 30.4327 5
PIICP change at 3 m 12.2862 4
PIICP change at 6 m 2.3888 5
COMP: cartilage oligomeric matrix protein, Col II: collagen type II-spec
propeptides; m: months.
* P< 0.05 (signiﬁcant).loss alters the in vivo cartilage contact biomechanics by shift-
ing the contact location to smaller regions of thinner cartilage,
and by increasing the magnitude of the cartilage contact defor-
mation. It is presumed that cartilage morphological alteration
is accelerated in the knees with meniscal pathology; with
altered knee joint kinematics, the mechanical demand eventu-
ally exceeds the ability of the joint to repair itself, setting the
stage for OA development.23
In this study the mechanism of injury was non-signiﬁcant
trauma in 50% of patients. This ﬁnding is in agreement with
previous studies that reported that 52–92% of patients with
symptomatic knee osteoarthritis present with meniscal damage
when assessed by MRI to the contralateral normal knees.23
Quantitative MRI (qMRI), like 3D-WS-bSSFP sequence
used in this study, provides non-invasive and reliable data on
cartilage morphology in healthy subjects with different age
groups and different genders.24 Comprehensive knowledge of
the biochemical and biomechanical changes that occur with
OA may require a combination of various qMRI techniques.
The application of these qMRI techniques to the identiﬁcation
and monitoring of cartilage damage in individual patients for
the early diagnosis and treatment of OA would be clinically sig-
niﬁcant. However, assessment of other joint structures is not
possible. In fat-suppressed 3D-WS-bSSFP, the articular carti-
lage has very high signal intensity, joint ﬂuid has an intermedi-
ate to low signal intensity, and subchondral bone and bone
marrow are dark. Reported sensitivity and speciﬁcity for detec-
tion of cartilage loss are 75–85% and 95–97%, respectively.25
The cartilage morphology (including cartilage volume by
MRI and thickness by US) was investigated in the meniscec-
tomized knees and the contralateral intact knees with a mean
injury time of 6.4 months. Using the 3D cartilage models
(Fig. 1), the mean total cartilage volume was calculated for
the femur and tibia. The cartilage thickness was measured
within the weight-bearing area by US. In this study, the
contralateral knees were used as the control side for analyz-
ing the cartilage morphological changes in the post-meniscec-
tomy knees. It was found that the meniscectomized side
demonstrated a statistically signiﬁcant lower total knee carti-
lage volume compared with the control side. The percentage
of decrease in the total knee cartilage volume post-operatively
from pre-operatively was >10% in 13 patients (65%), this
value progressors of cartilage loss based on MRI measure-
ments of the cartilage volume as a biomarker.11 However, this
did not correlate with KOOS scores. As the articular cartilage
is avascular and aneural, early changes could be asymptomatic
or affecting the functional knee activity.25 Signiﬁcant rates of
cartilage loss are seen also in other studies; in subjects of postpost-operative.
d. deviation Correlation Sig.
1.73360
4.84876 .215 .364
5.26478
3.27000 .003 .989
0.50939
7.64208 .541 .014*
iﬁc neoepitope, PIICP: procollagen molecule of type II collagen C-
196 H.K. Koryem et al.partial meniscectomy compared with healthy controls
(difference 6.5% per year, 95% CI 3.7–9.3% per year;
P< 0.001).26 Even greater losses were observed at the central
medial tibial cartilage and medial femoral condyle (15% and
12% respectively).27 Greater losses are observed in this cohort
of Egyptian adults, this may have a genetic basis. The same
genes that promote healing after cartilage damage also appear
to protect against OA due to wear-and-tear processes. Osteo-
arthritis, like several other disorders, involves many genes that
each contribute in a small way to the disease process. It is
proved that there is a subtle genetic inﬂuence on OA risk, while
other genes are protective.28
There was no statistically signiﬁcant difference in total car-
tilage thickness of the knee between the meniscectomized side
and the control side. As cartilage layers exhibit a mean thick-
ness of only 1.3–2.5 mm throughout the human knees,28 so
small changes could not be accurately measured. Moreover,
it was measured at a single point.27
Joint injury, including meniscal injuries, triggers a lengthy
remodeling process in the cartilage and surrounding tissues
that has adverse biomechanical and biochemical consequences
that encourage joint degeneration. The metabolic sensitivity of
chondrocytes to such mechanical environment changes, com-
bined with the low adaptation potential of mature cartilage,
could lead to cartilage degeneration and premature osteoar-
thritis after meniscal injury.29 A signiﬁcant difference was
found between the patients at the preoperative markers assay
and controls in both the COMP and PIICP but not in Col
II. This could be explained by the articular cartilage trauma
associated with the initial knee trauma that caused meniscal
injury,23 however, chondral lesions were deﬁned arthroscopi-
cally in only two patients (10%).
Diagnostically, assays for type II collagen degradation,
when used alone or in combination with markers of collagen
synthesis, can distinguish populations with cartilage lesion
which exhibit progression of joint damage from non-progres-
sors.30 In this study, with the exception of PIICP a marker
of cartilage synthesis, none of the individual biochemical bio-
markers was a statistically signiﬁcant indicator of cartilage vol-
ume loss by MRI. The diagnostic accuracy of combinations;
the ratio of COMP and Col II to PIICP was high even higher
than PIICP alone. This may be due to the short follow up
duration, as COMP and Col II are promising in the evaluation
of knee OA severity.17 Progression was identiﬁed by the
increase in type II collagen degradation products compared
to a decrease in the propeptide marker of synthesis.31 Measure-
ment of biochemical marker change to predict MRI progres-
sion in patients revealed none of the individual or combined
biomarkers was a statistically signiﬁcant predictor of cartilage
loss. This may be a b error due to small sample size. It is hoped
that the availability of assays to measure degradative, syn-
thetic, and turnover products of cartilage matrix metabolism
in body ﬂuids offers opportunities to try and monitor cartilage
turnover in vivo.17
5. Conclusion
Cartilage volume loss as an MRI-based biomarker combined
with changes in cartilage matrix turnover detected by molecu-
lar biomarkers appears to reﬂect the initial changes associated
with cartilage degeneration and so identiﬁes a subgroup ofpatients whose losses could be a signiﬁcant initiation that
account for early OA. Genetics and gene therapy is another
new avenue which must be explored to treat non- or poorly-
healing cartilage defects. It is found that one-time measure-
ment of biochemical markers could not be reliable to predict
MRI progression in patients following meniscectomy, with
the possible exception of PIICP.
There is increasing evidence that the best solution may be a
panel of biomarkers, covering the range of physiological
effects, or indeed a combination of tissue biomarkers with
other parameters (e.g., US or MRI) into single diagnostic test.
Measuring markers of these processes would seem promising
as predictors of early and subsequent cartilage degeneration
at the individual level. Moreover, genetic markers might be
also useful predictors of prognosis. Genetic mapping may
reveal differences in diverse healing responses in multiple tis-
sues giving a way to new therapeutic targets designed to induce
or enhance regeneration and, potentially, protect from OA.Conﬂict of interest
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